UPLIZNA conc perf 100 mg/10ml 3 flac 10 ml
7680693220010
CH-69322
L04AA47
07.15.0.
1 / 3
google
Details
- Product number
- 6932201
- CPT
- -
- Packaging group
- 3
- Unit
- Durchstechflasche(n)
- Composition
- inebilizumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, natrii chloridum, trehalosum dihydricum, polysorbatum 80, aqua ad iniectabile, ad solutionem pro 10 ml corresp., natrium 16.1 mg.
Articles (1)
Uplizna 100 mg/10ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
3
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
16.1 MG | Substance | HBESI |
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69322
- Drug name
- Uplizna, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AA47
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 04/03/2024
- Authorization expiration date
- 03/03/2029
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- UPLIZNA conc perf 100 mg/10ml 3 flac 10 ml
- Description (DE)
- UPLIZNA Inf Konz 100 mg/10ml 3 Durchstf 10 ml
- Market launch
- 04/03/2024
- Narcotic (BTM)
- No